Related Experiment Video
Updated: Jun 30, 2026

An Introduction to Worm Lab: from Culturing Worms to Mutagenesis
Published on: January 12, 2011
Profile of Helen M. Piwnica-Worms
Abstract:
Helen M. Piwnica-Worms has devoted her career to uncovering how cancer cells evade control and resist treatment. From pioneering work on cell cycle checkpoints to revealing drug resistance mechanisms in breast cancer, her research spans the continuum from basic discovery to clinical translation. A leader in using patient-derived models, she has shown how tumors can adopt reversible, drug-tolerant states and develop resistance. Her recent PNAS Inaugural Article identifies two escape routes in BRCA1-mutant tumors treated with talazoparib, pointing to new combination therapies. She emphasizes the value of mentorship and persistence in science.
Insights
Dr. Piwnica-Worms researches cancer cell evasion and drug resistance, identifying escape routes in BRCA1-mutant tumors to develop new combination therapies.
Area of Science:
- Oncology
- Cancer Biology
- Translational Research
Background:
- Cancer cells develop resistance to treatments, evading therapeutic control.
- Understanding these resistance mechanisms is crucial for effective cancer therapy.
- Dr. Piwnica-Worms' career focuses on basic discovery to clinical translation of cancer research.
Related Concept Videos
Other Unique Bacteria
Diversity of Protists I
Diversity of Protists III
Amebiasis

